Increasing prevalence of various genetic disorders, chronic diseases and viral infections, rising research based activities in pharmaceutical and biotechnology companies, and increasing applications of synthesized oligonucleotides are some key factors expected to drive global market growth.
Increasing prevalence of various genetic disorders, chronic diseases and viral infections, rising research based activities in pharmaceutical and biotechnology companies, and increasing applications of synthesized oligonucleotides are some key factors expected to drive global market growth
According to Emergen Research, the global oligonucleotide synthesis market size was USD 3.98 billion in 2019 and is expected to reach USD 9.91 billion in 2027 and register a steady revenue CAGR of 12.8% during the forecast period, 2020-2027.
Market Dynamics:
Oligonucleotide synthesis is an extremely crucial laboratory technique that involves chemical synthesis of short nucleic acid fragments with defined chemical structures to control gene expression. This technique is widely used in laboratories in applications such as diagnostics, therapeutics, and academics as it is rapid and inexpensive access to tailor-made oligonucleotides of desired sequence. Factors such as increasing funds by government and private organizations, ongoing research on drug development and discovery, and rising number of synthetic biology and genome projects are expected to drive global market revenue growth during the forecast period. In addition, growing awareness about oligonucleotide synthesis, and improving research facilities and overall infrastructure are expected to fuel market growth going ahead.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/351
However, factors such as lack of standardized regulations, dearth of skilled experts in research laboratories, and few complexities associated with therapeutic oligonucleotides can hamper overall market growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Research Segment To Register Robust Revenue CAGR:
The research segment is expected to register robust revenue CAGR between 2020 and 2027 owing to increasing number of pharmaceutical and biotechnology companies across the globe and rising genome-based research and projects in academic research institutes.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/oligonucleotide-synthesis-market
Hospitals Segment to Account for Largest Revenue Share:
The hospital segment is expected to account for largest revenue share over the forecast period. This can be attributed to large patient pool, rapid adoption of advanced tools and techniques in many hospitals, growing demand for personalized medicine, and high usage of oligonucleotide drugs for diagnosis and treatment of various diseases.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market during the forecast period owing to increasing prevalence of various diseases, rising demand for personalized medicines, and presence of well-developed healthcare and research facilities.
Major Companies in the Market Include:
- GeneDesign, Inc.
- Sarepta Therapeutics, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Synthesis, Inc.
- Agilent Technologies, Inc.
- Biogen Idec International GmbH
- Nitto Denko Avecia, Inc.
- ATDBio Ltd
- Integrated DNA Technologies, Inc.
- GenScript, Inc.
For the purpose of this report, Emergen Research has segmented the global oligonucleotide synthesis market on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
- Linkers
- Synthesized Oligonucleotides
- Equipment
- Probe
- Adaptor
- Reagent
Application Outlook (Revenue, USD Billion; 2017-2027)
- Therapeutic
- Research
- Diagnostics
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Pharmaceutical
- Hospitals
- Biotechnology
- Laboratories
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/351
Regional Outlook (Revenue, USD Billion; 2017–2027)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@ https://www.emergenresearch.com/call-schedule/351
Read Latest Reports Published by Emergen Research:
Radiation Therapy Quality Assurance (QA) Phantoms Market
HD Maps for Autonomous Vehicles Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-oligonucleotide-synthesis-market